Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

432 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assays for the Evaluation of the Immune Response to Marburg and Ebola Sudan Vaccination-Filovirus Animal Nonclinical Group Anti-Marburg Virus Glycoprotein Immunoglobulin G Enzyme-Linked Immunosorbent Assay and a Pseudovirion Neutralization Assay.
Rudge TL Jr, Machesky NJ, Sankovich KA, Lemmon EE, Badorrek CS, Overman R, Niemuth NA, Anderson MS. Rudge TL Jr, et al. Among authors: anderson ms. Vaccines (Basel). 2022 Jul 29;10(8):1211. doi: 10.3390/vaccines10081211. Vaccines (Basel). 2022. PMID: 36016099 Free PMC article.
Development, qualification, and validation of the Filovirus Animal Nonclinical Group anti-Ebola virus glycoprotein immunoglobulin G enzyme-linked immunosorbent assay for human serum samples.
Rudge TL Jr, Sankovich KA, Niemuth NA, Anderson MS, Badorrek CS, Skomrock ND, Cirimotich CM, Sabourin CL. Rudge TL Jr, et al. Among authors: anderson ms. PLoS One. 2019 Apr 18;14(4):e0215457. doi: 10.1371/journal.pone.0215457. eCollection 2019. PLoS One. 2019. PMID: 30998735 Free PMC article. Clinical Trial.
Method feasibility for cross-species testing, qualification, and validation of the Filovirus Animal Nonclinical Group anti-Ebola virus glycoprotein immunoglobulin G enzyme-linked immunosorbent assay for non-human primate serum samples.
Niemuth NA, Rudge TL Jr, Sankovich KA, Anderson MS, Skomrock ND, Badorrek CS, Sabourin CL. Niemuth NA, et al. Among authors: anderson ms. PLoS One. 2020 Oct 29;15(10):e0241016. doi: 10.1371/journal.pone.0241016. eCollection 2020. PLoS One. 2020. PMID: 33119638 Free PMC article.
Efficacy of different AV7909 dose regimens in a nonclinical model of pulmonary anthrax.
Henning L, Anderson M, Triplett C, Smith T, Boyce K, Hendey L, Ridenour A, Eng J, Schaeufele D, Wilson E, Sabourin CL, Adams LE, Babas T, Parish L, Wolfe D. Henning L, et al. Hum Vaccin Immunother. 2023 Dec 15;19(3):2290345. doi: 10.1080/21645515.2023.2290345. Epub 2023 Dec 19. Hum Vaccin Immunother. 2023. PMID: 38115181 Free PMC article.
Evaluation of strategies to modify Anti-SARS-CoV-2 monoclonal antibodies for optimal functionality as therapeutics.
House RV, Broge TA, Suscovich TJ, Snow DM, Tomic MT, Nonet G, Bajwa K, Zhu G, Martinez Z, Hackett K, Earnhart CG, Dorsey NM, Hopkins SA, Natour DS, Davis HD, Anderson MS, Gainey MR, Cobb RR. House RV, et al. Among authors: anderson ms. PLoS One. 2022 Jun 3;17(6):e0267796. doi: 10.1371/journal.pone.0267796. eCollection 2022. PLoS One. 2022. PMID: 35657812 Free PMC article.
Pathophysiology of the rhesus macaque model for inhalational brucellosis.
Henning LN, Miller SM, Pak DH, Lindsay A, Fisher DA, Barnewall RE, Briscoe CM, Anderson MS, Warren RL. Henning LN, et al. Among authors: anderson ms. Infect Immun. 2012 Jan;80(1):298-310. doi: 10.1128/IAI.05878-11. Epub 2011 Nov 7. Infect Immun. 2012. PMID: 22064715 Free PMC article.
432 results